Menu
Log in
Forgot password
Log in
Forgot password

News

  • Home
  • Resources
  • Literature Updates
  • Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study

Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study

24 Oct 2025 10:19 AM | Anonymous member (Administrator)

Kohei Shitara; Sun Young Rha; Lucjan Wyrwicz; Takashi Oshima; Nina Karaseva; Mikhail Osipov; Hisateru Yasui; Hiroshi Yabusaki; Sergey Afanasyev; Young-Kyu Park; Salah Eddin Al-Batran; Takaki Yoshikawa; Patricio Yanez; Filippo Pietrantonio; Sara Lonardi; Xiao Fang; Yanfen Guan, MS Adriana Valderrama; Pierre Leconte; Pooja Bhagia; Yung-Jue Bang

Read Abstract: Pembrolizumab Plus Chemotherapy Versus Chemotherapy as Perioperative Therapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer: Final Analysis of the Randomized, Phase III KEYNOTE-585 Study

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software